DrugPatentWatch Database Preview
Drugs in Development Information for Valerian
» See Plans and Pricing
What is the drug development status for Valerian?
Valerian is an investigational drug.
There have been 9 clinical trials for Valerian.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2001.
The most common disease conditions in clinical trials are Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, and Parkinson Disease. The leading clinical trial sponsors are Pascoe Pharmazeutische Praeparate GmbH, Prof. Huss, and Boehringer Ingelheim.
Summary for Valerian
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2001-01-01) |
| Vendors | 0 |
Recent Clinical Trials for Valerian
| Title | Sponsor | Phase |
|---|---|---|
| Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine. | Universidad Autonoma de San Luis Potosí | Phase 3 |
| Therapeutic Effect of an Herbal Medicine on Anxiety | Millet Roux | Phase 3 |
| Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety | Marjan Industria e Comercio ltda | Phase 3 |
Clinical Trial Summary for Valerian
Top disease conditions for Valerian
Top clinical trial sponsors for Valerian
US Patents for Valerian
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
